InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
60,884.49
(
0.35%
)
Post# of 252782
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

pharmaclown35

Send PM Follow Ignore
Followers 1
Posts 202
Boards Moderated 0
Alias Born 01/23/2008

pharmaclown35

Re: DewDiligence post# 66684

Monday, 09/29/2008 10:57:38 PM

Monday, September 29, 2008 10:57:38 PM

Post# of 252782
agreed. dosing will be paramount in HCV. once a second/third generation PI comes out with once daily - it's game over.

any thoughts on potential for ritonovir boosting with 2nd/3rd generation PIs in development?

or did that theory die in 07 when they tested telaprevir / boce with ritonovir (Abbott)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up